245 related articles for article (PubMed ID: 24641480)
1. Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?
Scarisbrick JJ; Kim YH; Whittaker SJ; Wood GS; Vermeer MH; Prince HM; Quaglino P
Br J Dermatol; 2014 Jun; 170(6):1226-36. PubMed ID: 24641480
[TBL] [Abstract][Full Text] [Related]
2. Risk of progression of early-stage mycosis fungoides, 10-year experience.
Ariza Gómez SA; Dubeibe Abril PA; Niebles Sincelejo OE; Reina HSL
An Bras Dermatol; 2024; 99(3):407-413. PubMed ID: 38395632
[TBL] [Abstract][Full Text] [Related]
3. Mycosis fungoides and Sézary syndrome: clinical, histopathological and immunohistochemical review and update.
Yamashita T; Abbade LP; Marques ME; Marques SA
An Bras Dermatol; 2012; 87(6):817-28; quiz 829-30. PubMed ID: 23197199
[TBL] [Abstract][Full Text] [Related]
4. Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study.
Khodadoust MS; Rook AH; Porcu P; Foss F; Moskowitz AJ; Shustov A; Shanbhag S; Sokol L; Fling SP; Ramchurren N; Pierce R; Davis A; Shine R; Li S; Fong S; Kim J; Yang Y; Blumenschein WM; Yearley JH; Das B; Patidar R; Datta V; Cantu E; McCutcheon JN; Karlovich C; Williams PM; Subrahmanyam PB; Maecker HT; Horwitz SM; Sharon E; Kohrt HE; Cheever MA; Kim YH
J Clin Oncol; 2020 Jan; 38(1):20-28. PubMed ID: 31532724
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Factors and Survival Outcomes Among Patients With Mycosis Fungoides in China: A 12-Year Review.
Chen Z; Lin Y; Qin Y; Qu H; Zhang Q; Li Y; Wen Y; Sun J; Tu P; Gao P; Wang Y
JAMA Dermatol; 2023 Oct; 159(10):1059-1067. PubMed ID: 37585188
[TBL] [Abstract][Full Text] [Related]
6. Predictors for the use of systemic therapy in stage IB Mycosis fungoides.
Rodriguez E; Needle CD; Martinez MJ; Nohria A; Xing Y; Song C; Betensky R; Latkowski JA; Adotama P
Arch Dermatol Res; 2024 Jun; 316(6):337. PubMed ID: 38844623
[TBL] [Abstract][Full Text] [Related]
7. Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.
Quaglino P; Prince HM; Cowan R; Vermeer M; Papadavid E; Bagot M; Servitjie O; Berti E; Guenova E; Stadler R; Querfeld C; Busschots AM; Hodak E; Patsatsi A; Sanches J; Maule M; Yoo J; Kevin M; Fava P; Ribero S; Zocchi L; Rubatto M; Fierro MT; Wehkamp U; Marshalko M; Mitteldorf C; Akilov O; Ortiz-Romero P; Estrach T; Vakeva L; Enz PA; Wobser M; Bayne M; Jonak C; Rubeta M; Forbes A; Bates A; Battistella M; Amel-Kashipaz R; Vydianath B; Combalia A; Georgiou E; Hauben E; Hong EK; Jost M; Knobler R; Amitay-Laish I; Miyashiro D; Cury-Martins J; Martinez X; Muniesa C; Prag-Naveh H; Stratigos A; Nikolaou V; Quint K; Ram-Wolff C; Rieger K; Stranzenbach R; Szepesi Á; Alberti-Violetti S; Felicity E; Cerroni L; Kempf W; Whittaker S; Willemze R; Kim Y; Scarisbrick JJ
Br J Dermatol; 2021 Apr; 184(4):722-730. PubMed ID: 32479678
[TBL] [Abstract][Full Text] [Related]
8. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023.
Latzka J; Assaf C; Bagot M; Cozzio A; Dummer R; Guenova E; Gniadecki R; Hodak E; Jonak C; Klemke CD; Knobler R; Morrris S; Nicolay JP; Ortiz-Romero PL; Papadavid E; Pimpinelli N; Quaglino P; Ranki A; Scarisbrick J; Stadler R; Väkevä L; Vermeer MH; Wehkamp U; Whittaker S; Willemze R; Trautinger F
Eur J Cancer; 2023 Dec; 195():113343. PubMed ID: 37890355
[TBL] [Abstract][Full Text] [Related]
9. Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome (BIO-MUSE): Protocol for a Translational Study.
Belfrage E; Ek S; Johansson Å; Brauner H; Sonesson A; Drott K
JMIR Res Protoc; 2024 Apr; 13():e55723. PubMed ID: 38436589
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Primary Tumor Site on Survival in Mycosis Fungoides.
Go CC; Zhong A; Linaburg T; Briceño CA
Cutis; 2024 Apr; 113(4):177-182. PubMed ID: 38820109
[TBL] [Abstract][Full Text] [Related]
11. The biomarker landscape in mycosis fungoides and Sézary syndrome.
Dulmage B; Geskin L; Guitart J; Akilov OE
Exp Dermatol; 2017 Aug; 26(8):668-676. PubMed ID: 27897325
[TBL] [Abstract][Full Text] [Related]
12. Changes to Registered and Pivotal Clinical Trials after the 2011 Tri-Societies Guidelines for Clinical Endpoints and Response Criteria in Mycosis Fungoides and Sézary Syndrome.
Gunter SJ; Kim EJ
J Invest Dermatol; 2024 Apr; 144(4):855-861.e1. PubMed ID: 37925066
[TBL] [Abstract][Full Text] [Related]
13. Ultrahypofractionated Low-Dose Total Skin Electron Beam in Advanced-Stage Mycosis Fungoides and Sézary Syndrome.
Elsayad K; Weishaupt C; Moustakis C; Danzer MF; Müller EC; Rolf D; Stranzenbach R; Livingstone E; Booken N; Stadler R; Eich HT
Int J Radiat Oncol Biol Phys; 2023 Sep; 117(1):164-170. PubMed ID: 36893819
[TBL] [Abstract][Full Text] [Related]
14. Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression.
Fléchon L; Arib I; Dutta AK; Hasan Bou Issa L; Sklavenitis-Pistofidis R; Tilmont R; Stewart C; Dubois R; Poulain S; Copin MC; Javed S; Nudel M; Cavalieri D; Escure G; Gower N; Chauvet P; Gazeau N; Saade C; Thiam MB; Ouelkite-Oumouchal A; Gaggero S; Cailliau É; Faiz S; Carpentier O; Duployez N; Idziorek T; Mortier L; Figeac M; Preudhomme C; Quesnel B; Mitra S; Morschhauser F; Getz G; Ghobrial IM; Manier S
Blood Adv; 2024 Jun; 8(12):3109-3119. PubMed ID: 38513135
[TBL] [Abstract][Full Text] [Related]
15. Survival Analysis and Prognostic Factors in a Case Series of 148 Cutaneous T-Cell Lymphomas.
Moreno-Vílchez C; Servitje O; Íñiguez-Arroyo Ó; Muniesa C
Actas Dermosifiliogr; 2023 Dec; ():. PubMed ID: 38159841
[TBL] [Abstract][Full Text] [Related]
16. The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indications.
Mazzeo E; Rubino L; Buglione M; Antognoni P; Magrini SM; Bertoni F; Parmiggiani M; Barbieri P; Bertoni F
Rep Pract Oncol Radiother; 2014 Mar; 19(2):77-91. PubMed ID: 24936325
[TBL] [Abstract][Full Text] [Related]
17. Reply to letter to the editor (Manuscript # JAAD-D-22-03011R1).
LeWitt TM; Walker CJ; Espinosa ML; Chung C; Zhou XA; Guitart J
J Am Acad Dermatol; 2023 Jul; 89(1):e67. PubMed ID: 36948297
[No Abstract] [Full Text] [Related]
18. Clinical characteristics, initial treatment, and prognosis of mycosis fungoides and Sézary syndrome: A retrospective, single-center study at the Centre Hospitalier Universitaire of Quebec.
Lachance M; Thibeault MM
Ann Dermatol Venereol; 2023 Dec; 150(4):276-280. PubMed ID: 37777355
[No Abstract] [Full Text] [Related]
19. Single-cell RNA sequencing reveals the underlying mechanism of folliculotropism in folliculotropic mycosis fungoides.
Shi HZ; Tian CC; Kong YQ; Sun JF; Chen H
Exp Dermatol; 2024 Jan; 33(1):e14992. PubMed ID: 38284188
[No Abstract] [Full Text] [Related]
20. Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes.
Wang L; Ni X; Covington KR; Yang BY; Shiu J; Zhang X; Xi L; Meng Q; Langridge T; Drummond J; Donehower LA; Doddapaneni H; Muzny DM; Gibbs RA; Wheeler DA; Duvic M
Nat Genet; 2015 Dec; 47(12):1426-34. PubMed ID: 26551670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
